title: Association between adherence to folic acid supplements and serum folate, and plasma homocysteine among hemodialysis patients.
abstract: OBJECTIVE
  To examine the relationship between adherence to prescribed folic acid supplements and folic acid intake, serum folate and plasma homocysteine in hemodialysis patients. The effects of change in adherence patterns from enrollment to 1 year later on changes in these same measures were also assessed.
  
  
  METHODS
  Secondary data analysis.
  
  
  METHODS
  Eighty-six hemodialysis patients who participated in the Hemodialysis (HEMO) Study's Homocysteine ancillary study.
  
  
  METHODS
  Folic acid supplement intake, serum folate, and plasma homocysteine.
  
  
  RESULTS
  Eighty-eight percent of patients at enrollment and 91% 1 year later were adherent to prescribed folic acid supplements. Nonadherers had lower intakes of folic acid at both enrollment and 1 year later and lower serum folate levels at enrollment. Percent change was significantly different between the 3 adherence change groups for folic acid intake (P = .001) and plasma homocysteine (P < .001) from enrollment to 1 year later. The nonadherent group at enrollment had the lowest intakes and serum folate levels, and the highest plasma homocysteine levels. When they became adherent 1 year later, they had the greatest change in folic acid intake (5,461%; P = .03), coupled with a 69% increase in serum folate (P = .04) and a 29% decrease in plasma homocysteine (P = .03).
  
  
  CONCLUSIONS
  Hemodialysis patients who were nonadherent to folic acid supplement prescriptions had low folic acid intakes, low serum folates, and high homocysteine levels. When their adherence improved, folic acid intakes rose, serum folates increased, and plasma homocysteine levels decreased, although mild hyperhomocysteinemia persisted.
authors.affiliation: Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy, Tufts University, Boston, Massachusetts 02111, USA. june.leung@tufts.edu
authors.forename: June
authors.initials: J
authors.lastname: Leung
authors.forename: Johanna
authors.initials: J
authors.lastname: Dwyer
authors.forename: Patricia
authors.initials: P
authors.lastname: Hibberd
authors.forename: Paul
authors.initials: P
authors.lastname: Jacques
authors.forename: William
authors.initials: W
authors.lastname: Rand
authors.forename: Michael V
authors.initials: MV
authors.lastname: Rocco
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D019587:Dietary Supplements; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage* / Q000097:blood*; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D010349:Patient Compliance; D016032:Randomized Controlled Trials as Topic; D006435:Renal Dialysis; D014805:Vitamin B 12 / Q000008:administration & dosage; D025101:Vitamin B 6 / Q000008:administration & dosage
chemical_list: D006710:Homocysteine; D025101:Vitamin B 6; D005492:Folic Acid; D014805:Vitamin B 12